October 30th, 2006
According to a study funded by the National Cancer Institute, the chemicals founds in grape seeds were able to significantly inhibit the growth of colorectal tumors in both cell cultures and in mice.
The said study revealed a 44 percent reduction of advanced colorectal tumors in the animals, and also revealed, for the first time, the […]
By Gloria Gamat -- 0 comments
October 25th, 2006
According to a new study published online October 20, 2006 in the International Journal of Cancer (the official journal of the International Union Against Cancer or UICC), there is a significant link between high bread consumption and renal cell carcinoma and that eating a lot of pasta and rice may also raise the risk, while eating […]
By Gloria Gamat -- 0 comments
October 24th, 2006
Deciding whether to get a regular mammogram?
A new review of studies offers both the good and the bad news to women facing such a decision.
The good news being that screening mammography does reduce breast cancer mortality and the bad news is that women in a screened population are 30 percent more likely to be diagnosed […]
By Gloria Gamat -- 0 comments
October 22nd, 2006
Published recently in the open access journal Environmental Health that investigated over 30,000 deaths of workers who had been employed at IBM factories in the USA, revealed that workers at computer factories are at an increased risk of dying of cancer.
The study reveals that IBM factory workers were more likely to have died of cancer, […]
By Gloria Gamat -- 0 comments
October 21st, 2006
The spread of skin cancer cells through the blood by literally listening to their sound can now be detected, according to University of Missouri-Columbia researchers.
The novel, minimally invasive technique called photoacoustic detection causes melanoma cells to emit noise, enabling oncologists to spot early signs of metastases — as few as 10 cancer cells in a blood […]
By Gloria Gamat -- 2 comments
October 20th, 2006
Taxotere® (docetaxel) Injection Concentrate in combination with cisplatin and fluorouracil for the induction treatment of patients with inoperable locally advanced squamous cell carcinoma of the head and neck (SCCHN), has recently been approved by the USFDA.
Head and neck cancer is diagnosed each year in more than 640,000 people worldwide while more than 350,000 die from […]
By Gloria Gamat -- 0 comments
October 17th, 2006
St. Jude Children’s Research Hospital clinicians successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.
The St. Jude technique: allowing blood stem cells to come from parents or unmatched adult siblings thereby avoiding the aggressive, toxic treatments that usually must […]
By Gloria Gamat -- 0 comments
October 16th, 2006
Derived from Genta Incorporated (Nasdaq: GNTA)’s DNA/RNA Medicines Program, G4460 is the company’s new anticancer drug that uses antisense technology to target an oncogene known as c-myb that regulates key functions in cancer cells.
G4460 targets an oncogene product known as c-myb, which is a protein that directly binds to cellular DNA. C-myb is believed to regulate […]
By Gloria Gamat -- 0 comments
October 15th, 2006
The Lung Cancer Alliance (LCA) has applauded the USFDA on its recent approval of Avastin (bevacizumab) for the most common type of lung cancer.
Laurie Fenton, President of Lung Cancer Alliance in Washington, D.C. stated:
“Lung cancer is responsible for over one-third of all U.S. cancer deaths, killing more people than breast, prostate, colon, liver and kidney […]
By Gloria Gamat -- 0 comments
October 11th, 2006
Though less common than in women, male breast cancer is currently deadlier than testicular and prostate cancers combined.
Now we should remember that breast cancer is not just a woman’s disease.
As an educational campaign, the leading online men’s health authority, Men’s Health Network, is daring men to be aware of their risk for breast cancer.
In recognition […]
By Gloria Gamat -- 1 comment
Recent Comments